Fund Details
Time BioVentures
Overview
Investment portfolio
13rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
AdvanCell | Jul 2026Participated | $315 MSeries D | |
Waypoint Bio | May 2026Participated | $20 MSeries A | |
Commons Clinic | Jun 2025Participated | $26 MSeries B | |
Phantom Neuro | Apr 2025Participated | $19 MSeries A | |
Conceivable Life Sciences | Jan 2025Participated | $18 MSeries A | |
Rivermark Medical | Oct 2024Participated | $30 MSeries C | |
Brightside Health | Mar 2024Participated | $33 MSeries C | |
Commons Clinic | Oct 2023Participated | $20 MSeries A | |
BillionToOne | Dec 2022Participated | $84 MSeries C | |
Phantom Neuro | Sep 2022Led | $6 MOther Equity | |
BillionToOne | Mar 2022Participated | $125 MSeries C | |
NanoMosaic | Dec 2021Participated | $41 MSeries A | |
AdvanCell | Jul 2026Participated | $315 MSeries D | |
Waypoint Bio | May 2026Participated | $20 MSeries A | |
Commons Clinic | Jun 2025Participated | $26 MSeries B | |
Phantom Neuro | Apr 2025Participated | $19 MSeries A | |
Conceivable Life Sciences | Jan 2025Participated | $18 MSeries A | |
Rivermark Medical | Oct 2024Participated | $30 MSeries C | |
Brightside Health | Mar 2024Participated | $33 MSeries C | |
Commons Clinic | Oct 2023Participated | $20 MSeries A | |
BillionToOne | Dec 2022Participated | $84 MSeries C | |
Phantom Neuro | Sep 2022Led | $6 MOther Equity | |
BillionToOne | Mar 2022Participated | $125 MSeries C | |
NanoMosaic | Dec 2021Participated | $41 MSeries A |
13 Items
13
Items
...
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 6 |
| Series B | 0 | 1 |
| Series C+ | 0 | 5 |
| Other Equity | 1 | 0 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Oct '21 | 1 |
| Nov '21 | 0 |
| Dec '21 | 1 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 1 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 1 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 1 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 1 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 1 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 1 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 1 |
| Jun '26 | 0 |
| Jul '26 | 1 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 13 |
| Hardware & Robotics | 2 |
| Space & Frontier Tech | 2 |
| Enterprise Software | 1 |
| AI & Machine Learning | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 1 |
| $10M-$25M | 4 |
| $25M-$50M | 5 |
| $50M-$100M | 1 |
| $100M-$250M | 1 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 12 |
| Australia | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Hummingbird Ventures | 3 |
| RA Capital Management | 3 |
| Adams Street Partners | 2 |
| Baillie Gifford | 2 |
| Breakout Ventures | 2 |
| Cadence Healthcare Ventures | 2 |
| Courtside Ventures | 2 |
| Draper Associates | 2 |
| Fifty Years | 2 |
| Floating Point | 2 |
| Libertus Capital | 2 |
| LionBird | 2 |
| Neotribe Ventures | 2 |
| Norwest Venture Partners | 2 |
| Risk and Return | 2 |
| Abingworth | 1 |
| ACME | 1 |
| ACME Capital | 1 |
| Actual VC | 1 |
| Ally Bridge Group | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 1 | 8% |
| Participating | 12 | 92% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 100% |
| Co-led | 0 | 0% |
Team
D.A. Wallach
Co-Founder
Timothy Wright
General Partner